Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen, Agilent Post Strong Gains in BCW

Qiagen and Agilent both had strong stock gains during the past week, leading the BioCommerce Week Index of multi-platform molecular biology tool firms. Qiagen shares rose 10 percent, though the reason for the upward movement is not readily apparent. Agilent's shares climbed 9.78 percent, due largely to a report in the Wall Street Journal that the firm's semiconductor business could be sold as early as late this week for as much as $2.5 billion.

Overall, the Index gained 1.16 percent for the week, trailing the Dow Jones Industrial Average, which gained 1.4 percent, the Nasdaq, which rose 3.1 percent, and the Nasdaq Biotech Index, which gained a robust 5.1 percent for the week.

BioCommerce Week’s Index to the
Diversified Molecular Biology Tools Companies
Company
Ticker
Current Price
(
July 12, 2005)
Last Price
(July 5, 2005)
% Change
Agilent
A
25.93
23.62
9.78
Applied Biosystems
ABI
20.26
20.31
-0.25
Beckman
BEC
64.05
64.96
-1.40
Bio-Rad
BIO
59.8
58.85
1.61
Bruker
BRKR
4.13
4.13
0.00
GE
GE
35.1
34.72
1.09
Harvard Bio
HBIO
3.28
3.18
3.14
Invitrogen
IVGN
83.88
84.9
-1.20
Molecular Devices
MDCC
20.75
21.8
-4.82
PerkinElmer
PKI
20.04
19.7
1.73
Qiagen
QGEN
13.15
11.95
10.04
Sigma
SIAL
57.49
55.99
2.68
Strategene
STGN
8.73
8.59
1.63
Thermo
TMO
27.98
26.7
4.68
Waters
WAT
38.9
38.49
1.07
Index Average
32.23
31.86
1.16
The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.